Robert G Bristow
Overview
Explore the profile of Robert G Bristow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
219
Citations
9489
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arbet J, Yamaguchi T, Shiah Y, Hugh-White R, Wiggins A, Oh J, et al.
bioRxiv
. 2025 Feb;
PMID: 39990314
Prostate cancer is characterized by profound heterogeneity in its clinical trajectory. While genomic heterogeneity has been well-characterized, epigenomic heterogeneity remains less understood. To fill this gap, we compiled 2,149 multi-ancestric...
2.
Yamaguchi T, Houlahan K, Zhu H, Kurganovs N, Livingstone J, Fox N, et al.
Cancer Discov
. 2025 Feb;
PMID: 39945744
Newly diagnosed prostate cancers differ dramatically in mutational composition and lethality. The most accurate clinical predictor of lethality is tumor tissue architecture, quantified as tumor grade. To interrogate the evolutionary...
3.
Ali A, Elumalai T, Venkatesulu B, Hekman L, Mistry H, Sachdeva A, et al.
BMJ Oncol
. 2025 Jan;
3(1):e000193.
PMID: 39886173
Objective: To assess pathological characteristics, clinical features and outcomes of patients diagnosed with peripheral zone (PZ) and transition zone (TZ) prostate cancer after prostatectomy. Methods And Analysis: We systematically reviewed...
4.
Suvac A, Ashton J, Bristow R
Nat Rev Cancer
. 2025 Jan;
25(3):167-188.
PMID: 39875616
Intratumour hypoxia is a feature of all heterogenous solid tumours. Increased levels or subregions of tumour hypoxia are associated with an adverse clinical prognosis, particularly when this co-occurs with genomic...
5.
Jones R, Ruiz J, Scaramuzza S, Nath S, Liu C, Henklewska M, et al.
iScience
. 2024 Jul;
27(7):110260.
PMID: 39055910
To ensure timely duplication of the entire eukaryotic genome, thousands of replication machineries (replisomes) act on genomic DNA at any time during S phase. In the final stages of this...
6.
Jakobsdottir G, Dentro S, Bristow R, Wedge D
Bioinformatics
. 2024 Apr;
40(6).
PMID: 38656989
Motivation: Few methods exist for timing individual amplification events in regions of focal amplification. Current methods are also limited in the copy number states that they are able to time....
7.
Tan Q, Wang M, Yu M, Zhang J, Bristow R, Hill R, et al.
Neoplasia
. 2024 Apr;
51:100994.
PMID: 38569377
No abstract available.
8.
Woodcock D, Sahli A, Teslo R, Bhandari V, Gruber A, Ziubroniewicz A, et al.
Cell Genom
. 2024 Mar;
4(3):100511.
PMID: 38428419
The development of cancer is an evolutionary process involving the sequential acquisition of genetic alterations that disrupt normal biological processes, enabling tumor cells to rapidly proliferate and eventually invade and...
9.
Zlotta A, Ballas L, Niemierko A, Lajkosz K, Kuk C, Miranda G, et al.
Lancet Oncol
. 2023 May;
24(6):669-681.
PMID: 37187202
Background: Previous randomised controlled trials comparing bladder preservation with radical cystectomy for muscle-invasive bladder cancer closed due to insufficient accrual. Given that no further trials are foreseen, we aimed to...
10.
Dubec M, Buckley D, Berks M, Clough A, Gaffney J, Datta A, et al.
Radiother Oncol
. 2023 Mar;
183:109592.
PMID: 36870608
Background And Purpose: Tumour hypoxia is prognostic in head and neck cancer (HNC), associated with poor loco-regional control, poor survival and treatment resistance. The advent of hybrid MRI - radiotherapy...